Previous 10 | Next 10 |
Neovasc (NASDAQ:NVCN) is scheduled to announce Q3 earnings results on Tuesday, November 9th, after market close. The consensus EPS Estimate is -$0.09 (+82.4% Y/Y) and the consensus Revenue Estimate is $1.2M (+90.5% Y/Y). Over the last 3 months, EPS estimates have seen 0 upward revisions and 1...
Vancouver, British Columbia--(Newsfile Corp. - November 1, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN), will report financial results for the quarter ended September 30, 2021 on Tuesday, November 9, 2021. Neovasc's President and Chief Executive Officer Fred Colen, and Chris Clark, C...
Publication Highlights Device Success in Chronic Total Occlusions of the Right Coronary Artery VANCOUVER and MINNEAPOLIS - ( NewMediaWire ) - October 21, 2021 - Neovasc Inc. (“Neovasc” or the “Company”) ( NASDAQ , TSX : NVCN) today anno...
Publication Highlights Device Success in Chronic Total Occlusions of the Right Coronary Artery VANCOUVER and MINNEAPOLIS, Oct. 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) ( NASDAQ , TSX : ...
VANCOUVER and MINNEAPOLIS - ( NewMediaWire ) - September 28, 2021 - Neovasc Inc. (“Neovasc” or the “Company”) ( NASDAQ , TSX : NVCN) today announced the publication of an article entitled, “Coronary sinus narrowing for the treatment...
Neovasc Inc. (NASDAQ: NVCN) is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. The Company is a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, and m...
VANCOUVER and MINNEAPOLIS - ( NewMediaWire ) - September 23, 2021 - Neovasc, Inc. (“Neovasc” or the “Company”) ( NASDAQ , TSX : NVCN) today announced that its management team will be participating in the 2021 Benzinga Healthcare Small Cap Confer...
Company on Schedule to Commence Trial Late This Year VANCOUVER and MINNEAPOLIS - ( NewMediaWire ) - September 16, 2021 - Neovasc Inc . (“Neovasc” or the “Company”) ( Nasdaq , TSX : NVCN) announced today that it has received FDA approval for th...
VANCOUVER and MINNEAPOLIS - ( NewMediaWire ) - August 30, 2021 - Neovasc, Inc. (“Neovasc” or the “Company”) ( NASDAQ , TSX : NVCN) today announced that its management team will be participating in the 23 rd Annual H.C. Wainwright Global Investme...
Presentation Times Released for 50 Presenting Companies Wednesday and Thursday, August 18-19, 2021 NEW YORK, NY / ACCESSWIRE / August 18, 2021 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day summer Microcap Virtual Conference taking pl...
News, Short Squeeze, Breakout and More Instantly...
Neovasc Inc. (NASDAQ: NVCN) is the focus of IBN's latest stock spotlight. The company's shares have moved -1.48% on the day to $29.23. Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. It...
VANCOUVER and MINNEAPOLIS, MN, March 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today reported financial results for the fourth quarter and year ended December 31, 2022. Recent Hi...
VANCOUVER, BC, March 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive devices for the treatment of refractory angina, is pleased to announce that its Shareholders (as d...